Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
124 studies found for:    aspirin | United States, New York | Studies with Male Participants
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed
Has Results
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Conditions: Heart Disease;   Stroke;   Ischemic Heart Disease;   Myocardial Infarction
Interventions: Drug: aspirin;   Drug: Warfarin
2 Active, not recruiting Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Condition: Cancer Patients First-ever Acute Ischemic Stroke
Interventions: Drug: Enoxaparin;   Drug: Aspirin
3 Recruiting Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
4 Recruiting A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Condition: Acute Coronary Syndromes
Interventions: Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
5 Active, not recruiting A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
Condition: Moderate Risk of CVD
Interventions: Drug: Aspirin (Acetylsalicylic acid, BAYE4465);   Drug: Placebo
6 Completed Secondary Prevention of Small Subcortical Strokes Trial
Conditions: Cerebrovascular Accident;   Hypertension
Interventions: Drug: aspirin;   Drug: clopidogrel;   Other: Target of Blood Pressure;   Other: placebo
7 Completed [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Conditions: Acute Ischaemic Stroke;   Transient Ischaemic Attack.
Interventions: Drug: ticagrelor;   Drug: Acetylsalicylic acid (ASA)
8 Completed Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Condition: Colorectal Cancer
Interventions: Drug: aspirin;   Other: placebo
9 Completed
Has Results
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
Condition: Acute Migraine
Interventions: Drug: Acetaminophen 250 mg and Aspirin 250 mg;   Drug: Placebo
10 Recruiting Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Condition: Prevention &Amp; Control
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
11 Enrolling by invitation ASPREE Cancer Endpoints Study
Condition: Cancer
Interventions: Drug: Aspirin;   Drug: Placebo
12 Recruiting Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
Condition: Thrombosis
Interventions: Drug: BMS-986141;   Drug: Aspirin;   Other: Placebo
13 Terminated Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
14 Recruiting A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS)
Condition: Brain Ischemia
Interventions: Drug: alteplase [Activase];   Drug: alteplase placebo;   Drug: aspirin;   Drug: aspirin placebo
15 Completed
Has Results
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Conditions: Chronic Total Occlusion of Coronary Artery;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Interventions: Drug: placebo + aspirin;   Drug: clopidogrel + aspirin OR prasugrel + aspirin;   Device: XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)
16 Completed Warfarin and Antiplatelet Therapy in Chronic Heart Failure
Condition: Heart Failure
Interventions: Drug: Warfarin titrated to an INR of 2.5-3.0;   Drug: Aspirin;   Drug: Clopidogrel 75
17 Completed
Has Results
The Dual Antiplatelet Therapy Study (DAPT Study)
Condition: Coronary Artery Disease
Interventions: Drug: Placebo & Aspirin;   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin
18 Recruiting Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Aspirin
19 Completed
Has Results
Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
Condition: Pain, Migraine
Interventions: Drug: Aspirin, acetaminophen and caffeine;   Drug: Sumatriptan;   Drug: Placebo
20 Completed
Has Results
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Commercially-available Aspirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years